TriMas Q4 Revenue $155.49M, Below Consensus
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 4 days ago
0mins
Should l Buy TRS?
Reports Q4 revenue $155.49M, consensus $192.96M. "We finished 2025 with a solid performance at the upper end of our earnings per share guidance range, supported by continued strong top-line growth and disciplined execution across our businesses," said Thomas Snyder, TriMas President and Chief Executive Officer. "Since stepping into the CEO role last June, my focus has been on building momentum and positioning TriMas for its next chapter. Our previously announced Aerospace transaction continues to progress as planned, with completion expected in mid-to-late March. In parallel, we are realigning TriMas for the future, streamlining our operating structure, executing cost-out initiatives and creating a more agile, customer-centric organization. The proceeds of the Aerospace divestiture will enable us to invest in our business, expand further into attractive packaging and life sciences opportunities, accelerate value creation and deliver compelling long-term returns for our shareholders."
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TRS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TRS
Wall Street analysts forecast TRS stock price to rise
2 Analyst Rating
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 39.080
Low
38.00
Averages
41.50
High
45.00
Current: 39.080
Low
38.00
Averages
41.50
High
45.00
About TRS
TriMas Corporation manufactures a diverse set of products for the consumer products, aerospace and industrial markets through its TriMas Packaging, TriMas Aerospace and Specialty Products groups. Its Packaging segment consists of the Rieke, Affaba & Ferrari, Taplast, Rapak, Plastic Srl, Aarts Packaging, Intertech, and Omega brands. It develops and manufactures a range of dispensing products, polymeric and steel caps and closures, polymeric jar products, fully integrated dispensers for fill-ready bag-in-box applications, and consumable vascular delivery and diagnostic test components. Its Aerospace segment includes the Monogram Aerospace Fasteners, Allfast Fastening Systems, Mac Fasteners, TFI Aerospace, RSA Engineered Products, Martinic Engineering and Weldmac Manufacturing Company brands, develops, qualifies and manufactures fasteners, tubular products and assemblies for fluid conveyance and machined products and assemblies. The Specialty Products segment includes the Norris Cylinder.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
TriMas Corporation Q4 2025 Earnings Call Insights
- Strategic Transformation: CEO Thomas Snyder emphasized that 2025 is a pivotal year for TriMas, launching a global operational excellence program aimed at enhancing efficiency through Lean Six Sigma principles, with further expansion planned for 2026.
- Financial Performance: Q4 net sales reached $256 million, a 12.5% increase year-over-year, while full-year sales exceeded $1 billion, up 12.7%, indicating strong growth potential in the Packaging and Specialty Products sectors.
- Cost Control: The company implemented a company-wide realignment, expecting over $10 million in cost reductions in 2026, which will enhance profitability, particularly with adjusted operating profit growing over 30% to $149 million for the year.
- Capital Deployment: TriMas plans to focus on selective acquisitions in the Packaging and Life Sciences sectors following the $1.45 billion divestiture of its Aerospace segment, while increasing share repurchase authorization to $150 million to enhance shareholder returns.
See More
TriMas Q4 Earnings Exceed Expectations
- Earnings Beat: TriMas reported Q4 adjusted earnings that exceeded analyst expectations, indicating strong performance in the market, which could enhance investor confidence.
- Positive Market Reaction: Following the earnings beat, TriMas shares climbed in Thursday trading, reflecting market optimism regarding the company's future growth potential, potentially attracting more investor interest.
- Increased Analyst Attention: With the improvement in earnings, analysts may reassess TriMas's investment ratings, further driving stock price increases and bolstering market confidence in its long-term development.
- Optimistic Industry Outlook: TriMas's robust performance may signal a recovery for the entire industry, drawing more investor attention to investment opportunities in related sectors and promoting overall industry growth.
See More
TriMas Increases Stock Buyback Authorization to $150 Million
- Buyback Authorization Increase: TriMas' board has raised its stock buyback authorization to $150 million, up from the previous $48.9 million, reflecting the company's confidence in its long-term value and expected to enhance shareholder returns.
- Significant Buyback Progress: In 2025, TriMas repurchased 3,124,866 shares of common stock for $103.3 million, with over three million shares bought back since the aerospace divestiture announcement, indicating a proactive capital allocation strategy.
- Outstanding Shares Overview: As of December 31, 2025, TriMas had approximately 37.6 million shares outstanding, and the implementation of the buyback plan is likely to reduce market float, potentially boosting earnings per share.
- Enhanced Strategic Flexibility: TriMas President and CEO Thomas Snyder stated that the increased buyback authorization provides greater flexibility to support strategic priorities and complete pending divestitures, showcasing the company's forward-thinking approach to capital management.
See More
TriMas Q4 Earnings Beat Expectations Despite Revenue Miss
- Earnings Beat: TriMas reported a Q4 GAAP EPS of $2.03, exceeding expectations by $1.59, indicating strong profitability despite revenue challenges.
- Revenue Miss: The reported revenue of $155.4 million fell short of the anticipated $191 million, highlighting sales difficulties that could impact future growth outlook.
- Increased Buyback Authorization: TriMas raised its share repurchase authorization to $150 million, reflecting confidence in its stock and potentially enhancing shareholder value by reducing outstanding shares.
- Market Interest Rating: Seeking Alpha's Quant Rating on TriMas indicates market interest, suggesting that despite revenue challenges, the improvement in profitability may attract more investor attention.
See More
TriMas Reports Significant Earnings Growth in Q4
- Significant Earnings Increase: TriMas Corp. reported fourth-quarter earnings of $81.70 million, translating to $2.03 per share, a substantial rise from last year's $5.64 million and $0.14 per share, indicating a marked improvement in the company's profitability.
- Adjusted Earnings Performance: Excluding special items, TriMas reported adjusted earnings of $16.25 million or $0.40 per share, reflecting a solid performance in its core business and further bolstering investor confidence.
- Revenue Growth: The company's revenue for the fourth quarter rose by 3.8% to $155.49 million from $149.73 million last year, demonstrating stable market demand and the competitiveness of its products.
- Financial Health: TriMas's robust earnings and revenue growth not only enhance its financial health but also provide ample funding for future investments and expansions, strengthening its competitive position in the industry.
See More
Trimas Declares Quarterly Dividend of $0.04
- Quarterly Dividend Announcement: Trimas has declared a quarterly dividend of $0.04 per share, consistent with previous distributions, indicating stable cash flow and profitability, which bolsters investor confidence.
- Dividend Yield: The forward yield of 0.43% reflects the company's attractiveness in the current market environment, aiding in attracting investors seeking stable returns.
- Payment Schedule: The dividend will be payable on March 6, with a record date of February 27 and an ex-dividend date also on February 27, ensuring shareholders receive timely returns and enhancing their willingness to hold shares.
- Financial Transparency: Trimas provides a dividend scorecard and yield chart, further enhancing the transparency of its financial information, helping investors better assess the company's financial health and future growth potential.
See More
TriMas Corporation Q4 2025 Earnings Call Insights
- Strategic Transformation: CEO Thomas Snyder emphasized that 2025 is a pivotal year for TriMas, launching a global operational excellence program aimed at enhancing efficiency through Lean Six Sigma principles, with further expansion planned for 2026.
- Financial Performance: Q4 net sales reached $256 million, a 12.5% increase year-over-year, while full-year sales exceeded $1 billion, up 12.7%, indicating strong growth potential in the Packaging and Specialty Products sectors.
- Cost Control: The company implemented a company-wide realignment, expecting over $10 million in cost reductions in 2026, which will enhance profitability, particularly with adjusted operating profit growing over 30% to $149 million for the year.
- Capital Deployment: TriMas plans to focus on selective acquisitions in the Packaging and Life Sciences sectors following the $1.45 billion divestiture of its Aerospace segment, while increasing share repurchase authorization to $150 million to enhance shareholder returns.
See More
TriMas Q4 Earnings Exceed Expectations
- Earnings Beat: TriMas reported Q4 adjusted earnings that exceeded analyst expectations, indicating strong performance in the market, which could enhance investor confidence.
- Positive Market Reaction: Following the earnings beat, TriMas shares climbed in Thursday trading, reflecting market optimism regarding the company's future growth potential, potentially attracting more investor interest.
- Increased Analyst Attention: With the improvement in earnings, analysts may reassess TriMas's investment ratings, further driving stock price increases and bolstering market confidence in its long-term development.
- Optimistic Industry Outlook: TriMas's robust performance may signal a recovery for the entire industry, drawing more investor attention to investment opportunities in related sectors and promoting overall industry growth.
See More
TriMas Increases Stock Buyback Authorization to $150 Million
- Buyback Authorization Increase: TriMas' board has raised its stock buyback authorization to $150 million, up from the previous $48.9 million, reflecting the company's confidence in its long-term value and expected to enhance shareholder returns.
- Significant Buyback Progress: In 2025, TriMas repurchased 3,124,866 shares of common stock for $103.3 million, with over three million shares bought back since the aerospace divestiture announcement, indicating a proactive capital allocation strategy.
- Outstanding Shares Overview: As of December 31, 2025, TriMas had approximately 37.6 million shares outstanding, and the implementation of the buyback plan is likely to reduce market float, potentially boosting earnings per share.
- Enhanced Strategic Flexibility: TriMas President and CEO Thomas Snyder stated that the increased buyback authorization provides greater flexibility to support strategic priorities and complete pending divestitures, showcasing the company's forward-thinking approach to capital management.
See More
TriMas Q4 Earnings Beat Expectations Despite Revenue Miss
- Earnings Beat: TriMas reported a Q4 GAAP EPS of $2.03, exceeding expectations by $1.59, indicating strong profitability despite revenue challenges.
- Revenue Miss: The reported revenue of $155.4 million fell short of the anticipated $191 million, highlighting sales difficulties that could impact future growth outlook.
- Increased Buyback Authorization: TriMas raised its share repurchase authorization to $150 million, reflecting confidence in its stock and potentially enhancing shareholder value by reducing outstanding shares.
- Market Interest Rating: Seeking Alpha's Quant Rating on TriMas indicates market interest, suggesting that despite revenue challenges, the improvement in profitability may attract more investor attention.
See More
TriMas Reports Significant Earnings Growth in Q4
- Significant Earnings Increase: TriMas Corp. reported fourth-quarter earnings of $81.70 million, translating to $2.03 per share, a substantial rise from last year's $5.64 million and $0.14 per share, indicating a marked improvement in the company's profitability.
- Adjusted Earnings Performance: Excluding special items, TriMas reported adjusted earnings of $16.25 million or $0.40 per share, reflecting a solid performance in its core business and further bolstering investor confidence.
- Revenue Growth: The company's revenue for the fourth quarter rose by 3.8% to $155.49 million from $149.73 million last year, demonstrating stable market demand and the competitiveness of its products.
- Financial Health: TriMas's robust earnings and revenue growth not only enhance its financial health but also provide ample funding for future investments and expansions, strengthening its competitive position in the industry.
See More
Trimas Declares Quarterly Dividend of $0.04
- Quarterly Dividend Announcement: Trimas has declared a quarterly dividend of $0.04 per share, consistent with previous distributions, indicating stable cash flow and profitability, which bolsters investor confidence.
- Dividend Yield: The forward yield of 0.43% reflects the company's attractiveness in the current market environment, aiding in attracting investors seeking stable returns.
- Payment Schedule: The dividend will be payable on March 6, with a record date of February 27 and an ex-dividend date also on February 27, ensuring shareholders receive timely returns and enhancing their willingness to hold shares.
- Financial Transparency: Trimas provides a dividend scorecard and yield chart, further enhancing the transparency of its financial information, helping investors better assess the company's financial health and future growth potential.
See More
